Antibiotice (BSE:ATB) Valuation Rank


BSE:ATB Antibiotice SA BSE:ATB
74 GF Score
Price lei2.16
GF Value lei2.19
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Antibiotice Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Antibiotice Valuation Rank Related Terms

BSE:ATB
74GF Score
Antibiotice SA BSE:ATB
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Antibiotice (BSE:ATB) Overvalued in 2026?

Based on GuruFocus' analysis, Antibiotice stock appears to be undervalued. The current stock price of lei2.16 is trading 1.4% below its estimated GF Value™ of lei2.19. GuruFocus considers Antibiotice to be Fairly Valued.

Key valuation signals for BSE:ATB:

  • Valuation Rank:
  • GF Value™: lei2.19 vs. price of lei2.16 (1.4% below fair value)
  • GF Score™: 74/100 with 6 warning signs

No single metric tells the full story. See the BSE:ATB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Antibiotice Business Description

Address 1 Valea Lupului Street, Iasi, ROU, 707410
Antibiotice SA is a Romania based company engaged in manufacturing generic medicines. It primarily develops and produces generic medicines for human use, veterinary medicines and active substance Nystatin. The group's generic medicines are primarily targeted at patients with infections, dermatological, cardiovascular, digestive tract diseases or diseases of the musculoskeletal system. It manufactures firm powders for solutions for injection and suspensions for injection (penicillins), capsules, tablets, suppositories and topical preparations (ointments, gels, creams).
74GF Score

Get the complete analysis for BSE:ATB

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

lei2.16
Price
lei2.19
GF Value